[Show abstract] [Hide abstract]
ABSTRACT: Outlining the treatment for an unclassifiable lymphoid malignancy is often difficult. A highly undifferentiated lymphomatous mass that relapsed in spite of intense chemotherapy and autologous transplant is reported. At relapse, there was differentiation into myeloid lineage. Though remission was achieved with AML-type reinduction chemotherapy, the mass recurred post allogenic cord blood stem cell transplant.
Pediatric Hematology and Oncology 04/2009; 26(2):93-9. DOI:10.1080/08880010902754883 · 1.10 Impact Factor